{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Ftoga-podcast.simplecast.com%2Fepisodes%2Fthe-role-of-liquid-biopsy-in-modern-oncology-Jsjr0p72","width":444,"version":"1.0","type":"rich","title":"The Role of Liquid Biopsy in Modern Oncology","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/37b381d6-a6e7-4025-a6ac-23a0ce7134b8/e738a046-6314-48fb-8ded-ecc836ddc6fb/50-liquid-biopsy.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/38a40229-13cb-4f4b-83c3-a57bb819221e\" height=\"200\" width=\"100%\" title=\"The Role of Liquid Biopsy in Modern Oncology\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this episode of Conversations in Lung Cancer Research, Dr. Malinda Itchins, Dr. Annie Wong, and A/Prof Stephen Kao discuss the concept of liquid biopsy, its advantages and limitations, and its clinical applications in lung cancer treatment. They explore how liquid biopsy can provide faster diagnosis and treatment options, especially for patients who cannot undergo traditional tissue biopsies. However, they also address the challenges of sensitivity and the need for further research to integrate liquid biopsy into routine clinical practice.\n\nThis episode is sponsored by: \n\nAstraZeneca  \n\nDaiichi Sankyo Australia  \n\nSOPHiA Genetics  \n\nThermo Fisher Scientific "}